Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry professionals · Thursday, March 28, 2024 · 699,419,493 Articles · 3+ Million Readers

Block & Leviton LLP Reminds Shareholders of Securities Class Action Against Immunomedics; Investors Are Encouraged to Contact the Firm

BOSTON, Jan. 18, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, reminds investors that it has filed a securities fraud class action against Immunomedics, Inc. (“Immunomedics” or the “Company”) (NASDAQ: IMMU) and certain of its officers and directors. The firm encourages shareholders to contact Block & Leviton LLP ahead of the February 25, 2019 lead plaintiff deadline.

The Complaint, filed in the United States District Court for the District of New Jersey, captioned Odeh v. Immunomedics, Incet al., Case No. 2:18-cv-17645, alleges that between August 23, 2018 and December 20, 2018, inclusive, the FDA cited Immunomedics for a host of regulatory violations which include "manipulated bioburden samples, misrepresentation of an integrity test procedure in the batch record, and backdating of batch records, such as dates of analytical results." On January 17, 2019, the FDA rejected Immunomedics’ breast cancer drug application due to these unresolved manufacturing issues. The case is pending in the District of New Jersey, Newark Courthouse, 50 Walnut Street, Newark, NJ07101. The case has been assigned to Judge Madeline Cox Arleo.

Following this news, Immunomedics stock price dropped from $17.64 at close on December 19, 2018, to $14.17 at close on December 20, 2018.

If you have purchased or otherwise acquired Immunomedics securities and have questions about your legal rights, or possess information relevant to this investigation, you are encouraged to contact Block & Leviton LLP at (617) 398-5660, (888) 868-2385, by email at info@blockesq.com, or by visiting http://shareholder.law/immunomedics.  

Block & Leviton LLP was ranked 4th among securities litigation firms by ISS for recoveries in 2017. The firm represents many of the nation's largest institutional investors and numerous individual investors in securities litigation throughout the country. Indeed, its lawyers have recovered billions of dollars for its clients.

This notice may constitute attorney advertising.

CONTACT:

BLOCK & LEVITON LLP
(617) 398-5660 phone
155 Federal Street, Suite 400
Boston, MA 02110
info@blockesq.com

SOURCE Block & Leviton LLP

Related Links

https://blockesq.com

Block & Leviton LLP Logo

Powered by EIN News
Distribution channels: Technology


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release